Proton Therapy Centre Quironsalud
Proton Therapy Centre Quironsalud
Spain, Madrid
Carme Ares
32 years of experience
Clinic is certified :
Sarcoma treatment cost in Spain typically involves a PET-CT scan running from $1,300 to $1,800 and primary Sarcoma surgery ranging from $30,900 to $40,000. Total expenses depend on tumor stage, surgical complexity, and the need for advanced radiotherapy. Patients often see 30-50% savings compared to the US. Top treatment hubs include Barcelona, Madrid, and Pamplona.
Typical Sarcoma Treatment Costs in Spain
Bookimed Expert Insight: Patients seeking limb preservation should prioritize specialized centers like Clinica Universidad de Navarra. They report a 95% limb preservation rate and a 74% cure rate for bone sarcomas. Pediatric cases are best managed at SJD Barcelona Children's Hospital, a top-ranked European institution. For advanced radiation, Quironsalud Madrid offers Spain's first proton therapy center for precise tumor targeting.
Head of the Sarcoma Unit at Teknon Medical Center — Dr. Galceran has performed over 1,200 treatments for sarcomas.
Awarded pediatric oncologist specializing in bone and soft tissue sarcomas. Heads the Hematology Oncology Department at SJD Barcelona Children's Hospital – ranked among Europe’s best.
Specialist in Orthopedic Surgery and Traumatology with a focus on sarcoma at Clinica Universidad de Navarra.
Top sarcoma hospitals in Spain include Clinica Universidad de Navarra and Centro Medico Teknon. These JCI-accredited centers specialize in complex bone and soft tissue tumors. They use advanced methods like proton therapy and limb-sparing surgery. Treatment focus includes high survival and function preservation.
Bookimed Expert Insight: Quality is consistent across major cities, but speed of access varies. Clinica Universidad de Navarra in Pamplona maintains a high 74% bone sarcoma cure rate. Meanwhile, Barcelona centers like Teknon offer rapid multidisciplinary coordination. Selecting a center with GEIS affiliation ensures access to the latest Spanish sarcoma clinical trials.
Patient Consensus: Patients emphasize finding a doctor who reviews documentation thoroughly before the first visit. They note that specialized units are often more efficient than large, general hospitals for scheduling.
Initial consultations should focus on subtype identification and multidisciplinary care. Ask about the precise sarcoma grade and mitotic rate. Confirm if genomic testing is required for targeted therapy. Ask about your specific risk profiles for limb-sparing surgery and long-term functional survival outcomes.
Bookimed Expert Insight: Spanish centers like Clinica Universidad de Navarra maintain a 95% limb preservation rate. This far exceeds general oncology averages. When consulting, ask your surgeon if they utilize high intensity focused ultrasound or specialized implants. Our data shows these leading centers focus heavily on functional recovery alongside a 74% bone sarcoma cure rate.
Patient Consensus: Patients note it's important to request a full pathology report including molecular markers like MDM2. Many recommend staying at JCI-accredited facilities in Barcelona or Madrid for faster scan turnaround times compared to public systems.
Spanish specialized centers report a 95% limb preservation rate for bone sarcomas. Expert units achieve a 74% average cure rate. Patients treated in designated high-volume facilities see an 82% 5-year survival rate. Advanced techniques like 3D custom implants and proton therapy drive these outcomes.
Bookimed Expert Insight: Clinica Universidad de Navarra demonstrates the value of massive patient volumes. They have treated 700,000 patients from 70 countries. This global experience contributes to their 74% 10-year survival rate for osteosarcoma. High-volume centers like this offer more specialized procedures such as mega-prostheses limb salvage.
Patient Consensus: Patients emphasize that early multidisciplinary tumor board reviews significantly improve the chances of saving a limb. Many note that choosing centers with 3D custom implant programs leads to much better post-op mobility.
Spanish hospitals preserve the affected limb in up to 95% of extremity sarcoma cases. Specialists in JCI-accredited centres like Clinica Universidad de Navarra use biological grafts and prosthetic implants. These procedures remove the tumour while maintaining limb function and appearance.
Bookimed Expert Insight: True limb-salvage expertise is concentrated in high-volume hubs like Pamplona and Barcelona. Clinica Universidad de Navarra stands out because its surgeons have treated over 700,000 international patients. This volume allows them to reach a 95% limb-preservation rate. This is significantly higher than general surgical units.
Patient Consensus: Patients note that Spanish specialists like Dr Joan Carles Galceran are well-prepared. These doctors provide exhaustive reports before travel. Patients often feel like welcome guests while receiving professional and kind support.
Spain provides radiation therapies such as proton beam therapy, CyberKnife, and MR-guided linear accelerators at JCI-accredited facilities. These technologies allow specialists to deliver high radiation doses to sarcomas. They do this while protecting nearby healthy organs. Most major centres in Madrid and Barcelona offer these protocols for adult and paediatric patients.
Bookimed Expert Insight: Spanish oncology centres often use US-trained specialists like Dr Carme Ares and Dr Jaume Mora Graupera. These doctors bring expertise from Memorial Sloan Kettering and MGH Boston. This international training and JCI-accredited infrastructure helps achieve high limb-preservation rates. This includes complex cases that might be deemed inoperable elsewhere. Proton therapy costs around A$72,900. These packages often include 3D CT scans and oncology-specific blood panels.
Patient Consensus: Patients in Spain note that specialists like Dr Joan Carles Galceran are well-prepared for consultations. They provide detailed written reports. Medical teams are described as kind and professional. They offer significant support through the diagnosis and treatment process.
Spain is a leading destination for sarcoma care due to centralised expertise. It achieves 90% limb-preservation rates for bone cancers. The country uses Proteus One proton therapy and multidisciplinary teams. These hubs offer surgical efficacy rates up to 90%. Costs are lower than in other Western nations.
Bookimed Expert Insight: Spain has effectively centralised sarcoma treatment into specialist hubs like those in Madrid and Barcelona. This concentration of volume is significant. For example, Hospital Ruber Internacional serves 25,000 patients annually. This high volume allows surgeons to maintain specialised skill sets often unavailable in general hospitals.
Patient Consensus: Patients note that Spanish oncologists like Dr Joan Carles are exceptionally well-prepared for consultations. They appreciate receiving comprehensive written reports. Many also feel like welcome guests during their treatment journey.
Immunotherapy and targeted therapy are available for advanced sarcomas in Spain. Major centres like Clinica Universidad de Navarra provide molecular profiling. This identifies specific mutations. Specialists then use drugs like Pazopanib or NTRK inhibitors. Immunotherapy remains a focused option for immunogenic subtypes like ASPS.
Bookimed Expert Insight: Spain ranks 5th globally for medical requests. This high volume drives faster access to clinical trials. Quironsalud Madrid oncologists include eligible international patients in cancer research studies. This offers access to treatments before they reach the general market. This is a vital option when standard therapies fail.
Patient Consensus: Patients find that Spanish specialists are thorough during consultations. They appreciate the detailed reports and direct access to experts like Dr Joan Carles Galceran. Many recommend arranging remote video reviews first. This confirms if a specific tumour subtype is eligible for targeted drugs before flying.
Spain designates eight public hospitals as CSUR reference centres for multidisciplinary sarcoma care. These hubs specialise in adult and paediatric musculoskeletal tumours. Leading private facilities also provide treatments like proton therapy and limb-sparing surgery. These centres use Proteus One technology and complex genomic diagnostics.
Bookimed Expert Insight: Spanish sarcoma care offers a unique advantage through private-public expertise. Public CSUR centres like Vall d Hebron lead research. Meanwhile, private specialists like Dr Joan Carles Galceran provide international patients with rapid access to these same protocols. This allows patients to get expert second opinions via telehealth before travelling for treatment.
Patient Consensus: Patients value the exhaustive documentation reviews conducted by specialists like Dr Joan Carles Galceran before appointments begin. Many note a high level of professional support throughout the diagnostic process in Spain.